Chen CS, Thai P, Yoneda K, Adler KB, Yang P-C, Wu R: A peptide that inhibits function of Myristoylated Alanine – Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis. Oncogene 33:3696–3706, 2014.
PMID: 23955080
PMCID: PMC4631387
DOI: 10.1038/onc.2013.336
Chen CS, Chiu CL, Adler KB, Wu R: A novel predictor of cancer malignancy and potential therapeutic target: Up-regulation of MARCKS phosphorylation in lung cancer. American Journal of Respiratory and Critical Care Medicine 189, 1002-1004, 2014.
PMID: 24735036
PMCID: PMC4098099
DOI: 10.1164/rccm.201401-0053LE
Sheats MK, Yin Q, Fang S, Crews AL, Adler KB: MARCKS protein and Lung Disease. American Journal of Respiratory Cell and Molecular Biology 60:16-27, 2019.
PMID: 30339463
PMCID: PMC6348718
DOI: 10.1165/rcmb.2018-0285TR
Scientific presentations:
Park J, Fang S, Yin Q, Crews AL, Adler KB: MARCKS binding to membrane phosphoinositide bisphosphate (PIP2) is involved in migration of lung cancer cells. American Journal of Respiratory and Critical Care Medicine 89; A5410, 2014. Presented at American Thoracic Society Annual Meeting, San Diego, CA, May 2014
Yin Q, Crews A, Fang S, Park J, Parikh I, Long W, Chen CH, Wu R, Adler KB: Inhibition of lung cancer metastasis in mice by inhaled aerosolized anti-MARCKS peptides. American Journal of Respiratory and Critical Care Medicine 191; A2429, 2015. Presented at American Thoracic Society Annual Meeting, Denver, CO, May 2015.
Fang S, Yin Q, Park J, Crews A, Dickson B, Adler KB: Synergy between anti-MARCKS peptides and chemotherapeutic agents in attenuation of NSCLC metastasis and tumor growth could be based on MARCKS cell cycle regulation. American Journal of Respiratory and Critical Care Medicine 193; A3131, 2016. Presented at American Thoracic Society Annual Meeting, San Francisco, CA, May 2016.
Park J, Fang S, Yin Q, Crews AL, Adler KB: Modulation of FAK activity by MARCKS is involved in migration of lung cancer cells. American Journal of Respiratory and Critical Care Medicine 193 A2365, 2016. Presented at American Thoracic Society Annual Meeting, San Francisco, CA, May 2016
Yin Q, Fang S, Park J, Crews A, Parikh I, Dickson B, Adler KB: MARCKS-inhibitory peptides synergize with cisplatin to inhibit metastasis and primary tumor growth in mouse orthotopic lung cancer models. American Journal of Respiratory and Critical Care Medicine 193, A3135, 2016. Presented at American Thoracic Society Annual Meeting, San Francisco, CA, May 2016
Yin Q, Fang S, JJ Park JJ, AL Crews AL, Dickson B, Parikh I, Adler KB: An inhibitor of MARCKS Protein Attenuates Migration of Human Lung Cancer cells; role of Protein Phosphatase Type 2A (PP2A) American Journal of Respiratory and Critical Care Medicine 195, A2357, 2017. Presented at American Thoracic Society Annual Meeting, Washington, DC, May 2017
Fang S, Yin Q, Park JJ, Crews AL, Dickson B, Adler KB: A Peptide Inhibitor of MARCKS Protein Attenuates Migration of Human Lung Cancer Cells; Cytoskeletal Rearrangement upon Treatment Indicates a Shift from Motile to Structural Cells. American Journal of Respiratory and Critical Care Medicine 195:A2358, 2017. Presented at American Thoracic Society Annual Meeting, Washington, DC, May 2017,
Adler KB, Dickson B: An inhaled MARCKS (Myristoylated Alanine-Rich C Kinase Substrate) -inhibitory drug, BIO-11006, elicited a statistically-significant result (p= 0.02) in Overall Response Rate (ORR) after 3 months compared to Standard of Care chemotherapy in a phase 2 trial of late stage Non Small Cell Lung Cancer (NSCLC). American J Resp Crit Care Med, In Press, 2020. To be presented at American Thoracic Society Annual Meeting, Philadelphia, PA (Meeting canceled due to COVID-19).
